Press release
Human Immunodeficiency Virus (HIV) Diagnosis Market Set to Reach $7.12 Billion by 2029 with 11% Yearly Growth
Human Immunodeficiency Virus (HIV) Diagnosis Market
The increasing number of blood donations is expected to drive the growth of the HIV diagnosis market. Blood donations have risen due to better donor recruitment strategies and advances in medical technology. More donations provide a larger pool of blood samples, enabling comprehensive HIV screening. For instance, NHS Blood and Transplant in the UK reported an increase in blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Therefore, the growth in blood donations is fostering the HIV diagnosis market.
Get Your Human Immunodeficiency Virus (HIV) Diagnosis Market Report Here:
https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report
What is the projected compound annual growth rate (CAGR) of the human immunodeficiency virus (hiv) diagnosis market from 2025 to 2034, and what factors influence it?
The HIV diagnosis market is projected to expand from $4.2 billion in 2024 to $4.68 billion in 2025 at a CAGR of 11.4%, attributed to voluntary counseling and testing, advanced antibody tests, HIV/AIDS epidemic responses, and community-led initiatives.
The HIV Diagnosis Market is projected to expand to $7.12 billion by 2029, with a CAGR of 11.0%. Growth is driven by public health campaigns, equity-focused testing, routine screenings, and self-testing expansions. Key trends include advancements in testing technology, targeted testing strategies, community-based outreach, and evolving policy and funding priorities.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp
How are the latest trends influencing the growth of the human immunodeficiency virus (hiv) diagnosis market?
Companies in the HIV diagnosis market are focusing on developing chip-based real-time PCR test solutions to enhance accuracy, reduce turnaround time, and improve accessibility. For example, in August 2022, Molbio Diagnostics, an India-based company, launched the Truenat HIV-1 test, a chip-based PCR test for detecting HIV-1 in blood and plasma. The test offers high accuracy, sensitivity, and specificity, with a minimal sample volume requirement. It also features an intelligent chip for quantifying results and a contamination-resistant design.
What are the major segments of the human immunodeficiency virus (hiv) diagnosis market and their role in driving growth?
The human immunodeficiency virus (HIV) diagnosis market covered in this report is segmented -
1) By Product: Consumables, Instruments, Software And Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions
Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15587
Which regions are key players in the growth of the human immunodeficiency virus (hiv) diagnosis market?
North America was the largest region in the HIV diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the human immunodeficiency virus (hiv) diagnosis market?
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15587&type=smp
What Is Covered In The Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report?
•Market Size Forecast: Examine the human immunodeficiency virus (hiv) diagnosis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the human immunodeficiency virus (hiv) diagnosis market for a structured understanding.
•Key Players Overview: Analyze major players in the human immunodeficiency virus (hiv) diagnosis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the human immunodeficiency virus (hiv) diagnosis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the human immunodeficiency virus (hiv) diagnosis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the human immunodeficiency virus (hiv) diagnosis market.
•Industry Challenges: Identify potential risks and obstacles affecting the human immunodeficiency virus (hiv) diagnosis market.
•Competitive Landscape: Review strategic developments in the human immunodeficiency virus (hiv) diagnosis market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Immunodeficiency Virus (HIV) Diagnosis Market Set to Reach $7.12 Billion by 2029 with 11% Yearly Growth here
News-ID: 3929722 • Views: …
More Releases from The Business research company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
